Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

TriLink BioTechnologies, Inc. Announces License Agreement with LI-COR Biosciences

Published: Friday, October 19, 2012
Last Updated: Friday, October 19, 2012
Bookmark and Share
TriLink BioTechnologies Inc. (TriLink) announced that it has recently signed a licensing agreement with LI-COR® Biosciences to custom label oligonucleotides, nucleotides, and nucleosides with IRDye® near-infrared dyes.

"This offers our customers a product option that will be more specific to their research, while being based on the IRDye near-infrared dye technology they have grown to trust," says Jim Wiley, LI-COR senior strategic marketing manager. "TriLink has established itself as an expert in the field of modified nucleic acids and we're certain our customers will benefit from this agreement."

LI-COR offers IRDye near-infrared dye technology that delivers enhanced sensitivity due to low background autofluorescence in the near-infrared region and, therefore, higher signal to noise ratios. IRDye near-infrared dyes have absorption and emission wavelengths in the near-infrared spectrum, between 650 nm and 800 nm.

"As experts in modified nucleic acid chemistry and leaders in dye labeling nucleoside triphosphates and oligonucleotides, we are continually expanding our portfolio of available modifications," says Richard Hogrefe, Ph.D., TriLink president and CEO. "The innovative LI-COR infrared dye series, IRDye 650-800, is a perfect fit, opening new doors for our customers seeking enhanced signal-to-noise ratios and dynamic range in applications where autofluorescence is an issue."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

TriLink BioTechnologies Announces Agreement with American Cleanroom Systems to build cGMP Facility
Agreement signed to build a 2,000 square foot pharmaceutical cGMP production suite within San Diego facility.
Thursday, October 24, 2013
TriLink Enters into Distribution Agreement with Astral Scientific
The agreement allows Astral to sell Trilink's modified nucleic acid products, including over 150 modified nucleotides, custom oligonucleotides and CleanAmp™ Hot Start PCR Products. The Australian based company supplies clinical diagnostic, life science and industrial markets.
Tuesday, November 15, 2011
TriLink Awarded Phase I Grant for a Second Hot Start PCR Project
TriLink Biotechnologies has received a $100,000 Phase I SBIR grant from the National Institutes of Health, to study an approach to PCR activation.
Tuesday, May 22, 2007
TriLink Awarded Phase II Grant for Start PCR Project
TriLink will optimize protocols for scale up and automated synthesis, in preparation for commercialization of the technology in early 2007.
Thursday, July 27, 2006
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
Genetic Tug of War
Researchers have reported on a version of genetic parental control in mice that is more targeted, and subtle than canonical imprinting.
Error Correction Mechanism in Cell Division
Cell biologists have reported an advance in understanding the workings of an error correction mechanism that helps cells detect and correct mistakes in cell division early enough to prevent chromosome mis-segregation and aneuploidy, that is, having too many or too few chromosomes.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
Researchers Resurrect Ancient Viruses
Researchers at Massachusetts Eye and Ear and Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina.
Cell Aging Slowed by Putting Brakes on Noisy Transcription
Experiments in yeast hint at ways to extend life of some human cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!